Cargando…
Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC
Tumor cell metabolism differs from that of normal cells, conferring tumors with metabolic advantages but affording opportunities for therapeutic intervention. Accordingly, metabolism-targeting therapies have shown promise. However, drugs targeting singular metabolic pathways display limited efficacy...
Autores principales: | Lucido, Christopher T., Miskimins, W. Keith, Vermeer, Paola D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316475/ https://www.ncbi.nlm.nih.gov/pubmed/30513596 http://dx.doi.org/10.3390/cancers10120476 |
Ejemplares similares
-
β(2)-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
por: Lucido, Christopher T., et al.
Publicado: (2018) -
mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC
por: Coppock, Joseph D., et al.
Publicado: (2016) -
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
por: Agnoletto, Chiara, et al.
Publicado: (2014) -
Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin
por: Ishiguro, Tatsuaki, et al.
Publicado: (2022) -
Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model
por: Su, Lei, et al.
Publicado: (2016)